Compounds > 1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole
Page last updated: 2024-09-03

1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole and Liver Cirrhosis

1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole has been researched along with Liver Cirrhosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Nucci, G; Ferraz, JG; Hofstätter, E; Leite, G; Leonardi, S; Magalhães, AF; Miranda, EL; Muscará, MN; Pedrazzoli, J1

Trials

1 trial(s) available for 1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole and Liver Cirrhosis

ArticleYear
Plasma hydroxy-metronidazole/metronidazole ratio in patients with liver disease and in healthy volunteers.
    British journal of clinical pharmacology, 1995, Volume: 40, Issue:5

    Topics: Adult; Biotransformation; Female; Half-Life; Humans; Liver Cirrhosis; Liver Function Tests; Male; Metronidazole; Middle Aged; Schistosomiasis mansoni

1995